Dysplastic nevus screening

Jump to: navigation, search

Dysplastic nevus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dysplastic nevus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dysplastic nevus screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dysplastic nevus screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dysplastic nevus screening

CDC on Dysplastic nevus screening

Dysplastic nevus screening in the news

Blogs on Dysplastic nevus screening

Directions to Hospitals Treating Dysplastic nevus

Risk calculators and risk factors for Dysplastic nevus screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Patients with dysplastic nevus should undergo regular screening to prevent progression to melanoma. According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for skin tumors, including dysplastic nevus or melanoma.

Screening

According to the National Cancer Institute, physicians believe that dysplastic nevi are more likely than ordinary moles to develop into a type of skin cancer called melanoma. Because of this, moles should be checked regularly by a physician or nurse specialist, especially if they look unusual; grow larger; or change in color, or outline; or if any changes occur. According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for skin tumors, including dysplasytic nevus and melanoma.[1]


References

  1. "USPSTF Skin Cancer Screening". Retrieved 20/8/2015. Check date values in: |access-date= (help)

Linked-in.jpg